Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-048913
Filing Date
2024-12-05
Accepted
2024-12-05 17:26:31
Documents
13
Period of Report
2024-11-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 26857
2 ex1.htm EX-1 18163
3 ex2.htm EX-2 47336
4 ex3.htm EX-3 447351
5 ex4.htm EX-4 295163
6 ex5.htm EX-5 14221
7 ex6.htm EX-10 14486
8 ex7.htm EX-7 82126
9 ex1_001.jpg GRAPHIC 8656
10 ex2_001.jpg GRAPHIC 24271
11 ex3_001.jpg GRAPHIC 21104
12 ex4_001.jpg GRAPHIC 21429
13 ex7_001.jpg GRAPHIC 15134
  Complete submission text file 0001493152-24-048913.txt   1072448
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 241529981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)